LMDX | LumiraDx Limited Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.0151 - 0.0282
52 Week Range	0.0151 - 0.0282
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	120,553,903
Average Volume	N/A
Shares Outstanding	N/A
Market Cap	249,627,216
Sector	Healthcare
Industry	Medical - Diagnostics & Research
IPO Date	2021-03-19

Valuation
Profitability
Growth
Health
P/E Ratio	-0.01
Forward P/E Ratio	-0.80
EPS	-1.08
1YR Price Target	4.00
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	1,210
Country	UK
Website	LMDX

LumiraDx Ltd is a next-generation point of care diagnostics company. It manufactures and commercializes an innovative diagnostic Platform that supports a broad menu of tests with lab comparable performance at the point of care.

LMDX's peers: AWH, BDSX, BNR, CHEK, CNTG, CSTL, DRIO, ENZ, FONR, MYNZ, NOTV, PMD, PRPH, PRPO, RDNT, SERA, STIM, STRR, XGN, LAB, PRE

*Chart delayed

Analyzing fundamentals for LMDX we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is very bad and Health is frighteningly weak. For more detailed analysis please see LMDX Fundamentals page.

Watching at LMDX technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, but short-term trend is bullish. More technicals details can be found on LMDX Technicals page.